EcoR1 Capital as of June 30, 2018
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 33 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Fibrogen (FGEN) | 12.0 | $126M | 2.0M | 62.60 | |
Ironwood Pharmaceuticals (IRWD) | 11.4 | $120M | 6.3M | 19.12 | |
Assembly Biosciences | 11.0 | $115M | 2.9M | 39.21 | |
Ascendis Pharma A S (ASND) | 9.3 | $97M | 1.5M | 66.52 | |
Kura Oncology (KURA) | 6.8 | $71M | 3.9M | 18.20 | |
Madrigal Pharmaceuticals (MDGL) | 5.3 | $56M | 200k | 279.69 | |
Celgene Corp option | 4.4 | $47M | 585k | 79.42 | |
Scholar Rock Hldg Corp (SRRK) | 4.0 | $42M | 2.7M | 15.60 | |
Dicerna Pharmaceuticals | 3.5 | $36M | 3.0M | 12.25 | |
Macrogenics (MGNX) | 2.9 | $30M | 1.5M | 20.65 | |
Ascendis Pharma A S call | 2.8 | $30M | 447k | 66.52 | |
Arcus Biosciences Incorporated (RCUS) | 2.6 | $27M | 2.2M | 12.24 | |
Unity Biotechnology | 2.4 | $25M | 1.7M | 15.06 | |
Kezar Life Sciences (KZR) | 2.1 | $22M | 1.3M | 17.30 | |
Fibrogen | 2.1 | $22M | 350k | 62.60 | |
Sangamo Biosciences (SGMO) | 2.0 | $21M | 1.5M | 14.20 | |
Magenta Therapeutics | 2.0 | $21M | 1.5M | 13.50 | |
Gilead Sciences Inc option | 2.0 | $21M | 293k | 70.84 | |
Immune Design | 1.9 | $20M | 4.4M | 4.55 | |
Wave Life Sciences (WVE) | 1.5 | $16M | 413k | 38.25 | |
Surface Oncology | 1.4 | $15M | 891k | 16.31 | |
Eiger Biopharmaceuticals | 1.2 | $13M | 1.0M | 12.20 | |
Achillion Pharmaceuticals | 1.1 | $11M | 3.9M | 2.83 | |
Ironwood Pharmaceuticals Inc cl a | 1.1 | $11M | 578k | 19.12 | |
Kadmon Hldgs | 0.9 | $10M | 2.5M | 3.99 | |
Dbv Technologies S A | 0.6 | $5.8M | 298k | 19.29 | |
Assembly Biosciences Inc call | 0.6 | $5.8M | 148k | 39.21 | |
Corvus Pharmaceuticals (CRVS) | 0.5 | $4.9M | 450k | 10.98 | |
Aquinox Pharmaceuticals | 0.3 | $3.0M | 1.2M | 2.65 | |
Onconova Therapeutics | 0.3 | $3.0M | 7.5M | 0.40 | |
Erytech Pharma Sa | 0.2 | $1.7M | 154k | 11.26 | |
Aptinyx | 0.1 | $992k | 41k | 24.17 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $787k | 412k | 1.91 |